Results of trial to stem hospital-acquired bacterial infections published

(NIH/National Institute of Allergy and Infectious Diseases) A trial evaluated whether daily bathing with the antiseptic soap chlorhexidine (CHG) -- and in those patients with MRSA, adding the nasal antibiotic mupirocin -- more effectively reduced hospital-acquired bacterial infections than bathing with ordinary soap and water. The researchers found that one subset of patients -- those with medical devices -- experienced a substantial benefit if they received the CHG/mupirocin intervention.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news